T-cell tolerant fraction as a predictor of immune-related adverse events

BACKGROUND: Immune checkpoint inhibitor (ICI) therapies may cause unpredictable and potentially severe autoimmune toxicities termed immune-related adverse events (irAEs). Because T cells mediate ICI effects, T cell profiling may provide insight into the risk of irAEs. Here we evaluate a novel metric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostmeyer, Jared, Park, Jason Y, von Itzstein, Mitchell S, Hsiehchen, David, Fattah, Farjana, Gwin, Mary, Catalan, Rodrigo, Khan, Shaheen, Raj, Prithvi, Wakeland, Edward K, Xie, Yang, Gerber, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432621/
https://www.ncbi.nlm.nih.gov/pubmed/37580069
http://dx.doi.org/10.1136/jitc-2022-006437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432621/
https://www.ncbi.nlm.nih.gov/pubmed/37580069
http://dx.doi.org/10.1136/jitc-2022-006437

Ejemplares similares